As a secondary result, the study revealed that visually detectable mucosal ischemia after ILA was apparent in ILA + over a period of > 45 min, whereas the persistence of ischemia was limited to 15 min when Articaine-4% without epinephrine (ILA-) was used (Fig. 5). The gene discussed is TNFRSF9; the disease is ischemia.